Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes

European Journal of Haematology

Volumn 62, Issue 1, 1999, Pages 19-26

  Parcharidou, Agapi ^a,c   Raza, Azra ^b   Economopoulos, Theofanis ^a   Papageorgiou, Efstathios ^a   Anagnostou, Dimitra ^c   Papadaki, Theodora ^c   Raptis, Sotirios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b RUSH CANCER INSTITUTE   (United States)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Apoptosis; ISEL technique; Myelodysplastic syndromes

Indexed keywords

APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DEATH; DNA CLEAVAGE; ENDOTHELIUM CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; LABELING INDEX; MYELODYSPLASTIC SYNDROME; PHAGOCYTOSIS; PRIORITY JOURNAL; STROMA CELL; TECHNIQUE; TISSUE SECTION;

EID: 0032939534     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01109.x     Document Type: Article

References (20)

1. KERR JFR, HARMON BV. Definition and incidence of apoptosis. An historical perspective In: TOMES LD, COPER FO, eds. Apoptosis: the molecular basis of cell death. New York: Cold Spring Harbor Laboratory Press, 1991:5-29.
2. WYLLIE AH, KERR JFR, CURRIE AR. Cell death: the significance of apoptosis. Intern Rev Cytol 1980;68:251-306.
3. ARENDS MJ, MORRIS RG, WYLLIE AH. Apoptosis: the role of the endonuclease. Am J Pathol 1990;136:593-608.
4. COHEN JJ, DUKE RC. Glycocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. Immunology 1984;132:38-42.
5. DURALL E, WYLLIE AH, MORRIS RG. Macrophages recognition of cells undergoing programmed cell death (apoptosis). Immunology 1985;56:351-358.
6. WIJSMAN JH, JONKER RR, KEIJZER R, et al. A new method to detect apoptosis in paraffin sections: in situ end labelling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
7. CLARK DM, LAMPERT TA. Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective haematopoiesis. Leuk Lymph 1990;2:415-418.
8. MUNDLE S, IFTICAR A, SHETTY V. In situ end labelling of DNA to detect apoptotic cell death in a variety of human tumors. Cell Death Diff 1994;1:117-122.
9. ECONOMOPOULOS T, STATHAKIS N, FOUDOULAKIS N, et al. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Eur J Haematol 1987;38:338-344.
10. YOSHIDA Y, STEPHENSON J, MUFTI G. Myelodysplastic syndromes from morphology lo molecular biology I. Classification, natural history and cell biology of myelodysplasia. Int J Haematol 1993;57:87.
11. BENNETT JM, COTOVSKY D, FLONDRIN G, et al. Proposals for the classification of myelodysplastic syndromes. Br J Haematol 1982:51.
12. GIAVRIELI Y, SHERMAN Y, BEN-SASSON SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. Cell Biol 1992;119:493-501.
13. KISHIMOTO M, UEDA K, NAKATA M, et al. Detection of DNA strand breaks by in situ nick translation using non-radioactive nucleotide. Proc Hist Soc J Histochem Cytochem 1990;38:1052 (abstr 154).
14. RAZA A, GEZER S, MUNDLE S, et al. Apoptosis in bone marrow biopsy samples involving stromal and haematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995;86:268-276.
15. LOTEM J, CRAGOE EJ Jr, SACHS L. Rescue from programmed cell death in leukemic and normal myeloid cells. Blood 1991;78:953-960.
16. TELFORD WG, KING LE, FRAKER PJ. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow-cytometry. Cytometry 1992;13:137-143.
17. EASTMAN A, BARRY MA. The origins of DNA breaks: a consequence of DNA damage: DNA repair or apoptosis. Cancer Invest 1992;10:229-240.
18. YOSHIDA Y. Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes. Leukemia 1993;7:144-146.
19. KANTER L, HELLSTROM-LINDBERG E, KOCK Y, RODENSJO M, OST A. Erythropoietic effectiveness and apoplosis in patients with myelodysplastic syndromes (MDS) treated with G-CSF and Epo. Proc Am Soc Hem Blood 1995;86:338 (abstr 1339).
20. RAZA A, MUNDLE S, IFTICAR A, GRECORY S, et al. Simultaneous assessments of cell kinetics and programmed cell death in bone marrow biopsies in myelodysplastics reveals extensive apoptosis as the probable basis of ineffective haematopoiesis. Am J Pathol 1995;48:143-154.